Medicine supply in Latin America

Pharma sales have been relatively healthy in Latin America over the past few years.

Indeed over the counter drugs consume a large section of the market, however the generic prescription drug is a swiftly growing category in the region. Brazil is the strongest pharmaceutical market, forecasted grow to US$29bn by 2021. Argentina is one of the more attractive regions in Latin America for manufacturers with the deployment of healthcare reforms, however poor access to medicines and hurdles with IP protection present tall challenges for the nation.

Supplying to emerging markets

To successfully supply medicines in this continent, market authorisation holders must equip themselves with the local expertise of Latin America's landscape in terms of its infrastructure, regulatory climate, weather and population forecasts. 

Download this infographic to explore the key elements impacting pharmaceutical supply chains running through Latin America. 

Stay tuned for part three of this infographic series looking at Latin America. 

Part One: Medicine logistics in emerging markets: Southeast Asia

Part Two: Medicine logistics in emerging markets: Africa